The A-Kinase Anchoring Protein (AKAP)-Lbc-Signaling Complex Mediates ␣1 Adrenergic Receptor-Induced Cardiomyocyte Hypertrophy
Total Page:16
File Type:pdf, Size:1020Kb
The A-kinase anchoring protein (AKAP)-Lbc-signaling complex mediates ␣1 adrenergic receptor-induced cardiomyocyte hypertrophy Aline Appert-Collin*, Susanna Cotecchia*, Monique Nenniger-Tosato*, Thierry Pedrazzini†, and Dario Diviani*‡ *De´partement de Pharmacologie et de Toxicologie, Faculte´de Biologie et de Me´decine, Universite´de Lausanne, 1005 Lausanne, Switzerland; and †Department of Medicine, University of Lausanne Medical School, 1011 Lausanne, Switzerland Edited by Robert J. Lefkowitz, Duke University Medical Center, Durham, NC, and approved May 1, 2007 (received for review February 6, 2007) In response to various pathological stresses, the heart undergoes (PKN) (7), and stress-activated protein (SAP) kinases (8), which a pathological remodeling process that is associated with cardio- control the transcription of genes involved in cardiomyocyte myocyte hypertrophy. Because cardiac hypertrophy can progress hypertrophy. to heart failure, a major cause of lethality worldwide, the intra- At the cellular level, the activation of Rho is controlled by Dbl cellular signaling pathways that control cardiomyocyte growth family guanine nucleotide exchange factors (GEFs), which all have been the subject of intensive investigation. It has been known share a Dbl homology (DH) domain and an adjacent pleckstrin for more than a decade that the small molecular weight GTPase homology (PH) domain (9). The DH domain is responsible for RhoA is involved in the signaling pathways leading to cardiomy- the guanine nucleotide exchange activity, whereas the PH do- ocyte hypertrophy. Although some of the hypertrophic pathways main controls the subcellular localization of the GEF or con- activated by RhoA have now been identified, the identity of the tributes to the binding pocket for Rho-GTPases (10). exchange factors that modulate its activity in cardiomyocytes is Recently, we identified an exchange factor expressed in the currently unknown. In this study, we show that AKAP-Lbc, an heart, termed AKAP-Lbc, which functions as GEF for RhoA as A-kinase anchoring protein (AKAP) with an intrinsic Rho-specific well as an A-kinase anchoring protein (AKAP) (11, 12). Inter- guanine nucleotide exchange factor activity, is critical for activat- ing RhoA and transducing hypertrophic signals downstream of estingly, AKAP-Lbc is regulated in a bidirectional manner by ␣1-adrenergic receptors (ARs). In particular, our results indicate signals that activate or deactivate its Rho-GEF activity. Activa- that suppression of AKAP-Lbc expression by infecting rat neonatal tion of AKAP-Lbc occurs in response to agonists that stimulate ventricular cardiomyocytes with lentiviruses encoding AKAP-Lbc- G proteins coupled receptors linked to the heterotrimeric G specific short hairpin RNAs strongly reduces both ␣1-AR-mediated protein G12 (11), whereas inactivation occurs through a mech- RhoA activation and hypertrophic responses. Interestingly, ␣1-ARs anism that requires phosphorylation of AKAP-Lbc by anchored promote AKAP-Lbc activation via a pathway that requires the ␣ PKA and subsequent recruitment of the regulatory protein subunit of the heterotrimeric G protein G12. These findings iden- 14-3-3 (13). tify AKAP-Lbc as the first Rho-guanine nucleotide exchange factor Although the implication of RhoA in the hypertrophic path- (GEF) involved in the signaling pathways leading to cardiomyo- ways activated by the ␣1-AR is known by more than a decade cytes hypertrophy. (14), the identity of the Rho-GEFs that mediate cardiomyocyte hypertrophy has remained elusive mainly because of the unavail- cardiac hypertrophy ͉ Rho GTPase ͉ G protein-coupled receptor ability of reagents capable of inhibiting the function of exchange factors in a specific manner. In the present study, we used a entricular myocyte hypertrophy is an adaptive growth re- lentivirus-based strategy to deliver AKAP-Lbc-specific short Vsponse to a stress placed on the heart promoting an increase hairpin (sh) RNAs into primary cultures of rat neonatal ven- in cardiac contractility. It is associated with a nonmitotic growth tricular cardiomyocytes (NVMs). Using this approach, we could of cardiomyocytes, increased myofibrillar organization, and up- demonstrate that AKAP-Lbc plays a key role in mediating regulation of specific subsets of ‘‘fetal’’ genes that are normally ␣1-AR-induced hypertrophic responses. In particular, we found expressed during embryonic life (1). Because hypertrophy can that AKAP-Lbc participates in a transduction pathway activated often progress to heart failure, a major cause of morbidity and by the ␣1-AR that includes G␣12, AKAP-Lbc, and RhoA that mortality worldwide, many efforts have been made during recent promotes cardiomyocyte hypertrophy. Therefore, our findings years to define the molecular players involved in this patholog- identify AKAP-Lbc as a Rho-GEF crucially involved in the ical process. transduction pathways associated to cardiomyocyte hypertrophy. In this respect, several lines of evidence collected over more then 10 years indicate that adrenergic transmission mediated by ␣1-adrenergic receptors (ARs) can initiate signaling pathways Author contributions: A.A.-C., S.C., and D.D. designed research; A.A.-C., M.N.-T., T.P., and that control cardiomyocyte hypertrophy both in vitro and in vivo D.D. performed research; T.P. contributed new reagents/analytic tools; A.A.-C. analyzed (2–4). ␣1-ARs are seven transmembrane domain receptors that data; and D.D. wrote the paper. can couple to and activate heterotrimeric G proteins of the Gq The authors declare no conflict of interest. and G12/G13 family (5). Although most of the studies have This article is a PNAS Direct Submission. focused on the role of the ␣ subunit of Gq in mediating the Abbreviations: AR, adrenergic receptor; GEF, guanine nucleotide exchange factor; AKAP, effects of ␣1-ARs on cardiomyocyte hypertrophy, recent evi- A-kinase anchoring protein; shRNA, short hairpin RNA; NVM, neonatal ventricular cardi- ␣ ␣ omyocyte; GPCR, G protein-coupled receptor; PE, phenylephrine; ANF, atrial natriuretic dence now suggests that G 12 and G 13 also contribute impor- factor; moi, multiplicity of infection; Ang-II, angiotensin II; ET-1, endothelin 1; LPA, ly- tantly to the growth responses induced by these receptors (5). In sophasphatidic acid. ␣ fact, it has been shown that 1-ARs, by means of the stimulation ‡To whom correspondence should be addressed at: De´partement de Pharmacologie et de of the ␣ subunits of G12 and G13, can promote the activation of Toxicologie, Rue du Bugnon 27, 1005 Lausanne, Switzerland. E-mail: [email protected]. the GTPase RhoA (5). In cardiomyocytes, this small molecular This article contains supporting information online at www.pnas.org/cgi/content/full/ weight GTP-binding protein promotes the activation of different 0701099104/DC1. effector kinases, including Rho kinase (5, 6), protein kinase N © 2007 by The National Academy of Sciences of the USA 10140–10145 ͉ PNAS ͉ June 12, 2007 ͉ vol. 104 ͉ no. 24 www.pnas.org͞cgi͞doi͞10.1073͞pnas.0701099104 Downloaded by guest on September 25, 2021 Results A 1000 PE ␣ PE 6h B 1-AR Stimulation Up-Regulates AKAP-Lbc ExpressionANRm in Cardiomyo- noisserpxe * )detaertnu PE 24h 0h 6h 24h cytes. Several lines of evidence demonstrate that RhoA plays an 800 kb important role in mediating the hypertrophic responses to ␣1-AR agonists in rat NVMs (5, 14), thus raising the question of 600 9.5 which cardiac Rho-GEF could mediate receptor-induced RhoA 7.5 400 activation. Interestingly, we found that primary cultures of rat 4.5 fo fo * NVMs express several Rho selective exchange factors including 200 AKAP-Lbc LARG, PDZ-Rho-GEF, p115 Rho-GEF, and AKAP-Lbc that %( are known to be activated by G protein-coupled receptors 0 (GPCRs) [supporting information (SI) Fig. 5] (11, 15–18). We AKAP p115 PDZ LARG Lbc Rho Rho 123 initially determined by real-time quantitative PCR whether the GAPDH expression of these exchange factors could be modulated in GEF GEF response to the hypertrophic stimulation of cardiomyocytes with C 700 Untr. noisserpxe ANRm noisserpxe D PE n phenylephrine (PE). Interestingly, we found%( that fo treatment of )detaertnu Ϫ4 ANR oisserpxe 600 PE * 1000 ISO * NVMs for 24 h with 10 M PE could increase AKAP-Lbc ) l Ͼ ortn mRNA expression by 7-fold without significantly affecting the 800 500 * mRNA expression of the other exchange factors (Fig. 1A). 400 600 o Up-regulation of AKAP-Lbc expression was already detectable c 300 * fo 6 h after PE treatment as assessed by Northern blot and by 400 200 real-time PCR (Fig. 1 B Upper and C), suggesting that that the % 200 ( stimulation of AKAP-Lbc expression precedes the phenotypic 100 appearance of the cardiomyocyte hypertrophy, which is detect- 0 m 0 6h 24h AKAP able 24 h after PE treatment. Moreover, stimulation of NVMs ANF Ϫ Lbc for 24 h with 10 4 M of isoproterenol did not induce any detectable increase in the expression of AKAP-LbcANRm suggesting E noisserpxe 700 that AKAP-Lbc up-regulation is selectively induced in response%( fo )lortnoc 600 Untreated to the chronic activation of ␣1-ARs but not -ARs (Fig. 1C). PE 24h We then examined whether AKAP-Lbc was also up-regulated 500 in vivo during pathological cardiac hypertrophy. To address this 400 issue we analyzed AKAP-Lbc expression in the left ventricular 300 tissue from mice that were subjected to a chronic infusion of PE 200 (100 g⅐kgϪ1⅐dayϪ1) for a period of 14 days (19). In agreement 100 * with previous reports, this chronic PE treatment increased the 0 * cardiac weight index by 21% (SI Fig. 6). Interestingly, we found Control shRNA Mutated that ventricular expression of AKAP-Lbc and that of the hyper- shRNA trophic marker atrial natriuretic factor (ANF) were increased in response to PE infusion by 3.5- and 4.6-fold, respectively (Fig. Fig. 1. PE selectively up-regulates AKAP-Lbc expression in cardiomyocytes. 1D). Altogether, these findings raise the intriguing hypothesis (A) Real-time PCR analysis of the mRNA expression of various Rho-GEFs was that AKAP-Lbc could participate in the early molecular events performed on total RNA samples extracted from rat NVMs that were left untreated or that were stimulated for 24 h with 10Ϫ4 M PE.